Liquiritigenin restores osteoblast damage through regulating oxidative stress and mitochondrial dysfunction

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Mitochondrial dysfunction contributes to osteoblast cytotoxicity.
• Flavonoids, like liquiritigenin from Glycyrrhizae radix, may offer protective effects.
• Oxidative stress is a key factor in mitochondrial damage.

Purpose of the Study:

• To investigate the protective effects of liquiritigenin against antimycin A-induced mitochondrial dysfunction in osteoblasts.
• To elucidate the role of phosphoinositide 3-kinase (PI3K) signaling in liquiritigenin's protective mechanism.
• To assess liquiritigenin's impact on oxidative stress markers and mitochondrial function.

Main Methods:

• MC3T3-E1 osteoblast cells were pre-incubated with liquiritigenin before exposure to antimycin A.
• Mitochondrial function markers (membrane potential, complex IV activity, ATP levels) were measured.
• Oxidative damage markers (superoxide generation, nitrotyrosine, cardiolipin peroxidation) were assessed.
• The involvement of PI3K was examined using a PI3K inhibitor (LY294002).

Main Results:

• Liquiritigenin significantly protected MC3T3-E1 cells from antimycin A-induced death.
• PI3K activation was crucial for liquiritigenin's cytoprotective effect, as shown by LY294002.
• Liquiritigenin pretreatment prevented PI3K inactivation, mitochondrial membrane potential loss, complex IV inactivation, and ATP depletion.
• Liquiritigenin reduced mitochondrial superoxide, nitrotyrosine, and cardiolipin peroxidation.

Conclusions:

• Liquiritigenin protects osteoblasts against mitochondrial oxidative stress through PI3K modulation and antioxidant effects.
• The study highlights liquiritigenin's potential to attenuate mitochondrial dysfunction.
• These findings suggest liquiritigenin as a promising agent for protecting osteoblasts from cytotoxicity.